A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients

Core Binding Factor (CBF)-AML is one of the most common somatic mutations in acute myeloid leukemia (AML). t(8;21)/AML1-ETO-positive acute myeloid leukemia accounts for 5-10% of all AMLs. In this study, we consecutively included 254 AML1-ETO patients diagnosed and treated at our institute from Decem...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Min, Zhao, Bide, Wang, Jinghan, Zhang, Yi, Hu, Chao, Liu, Lixia, Qin, Jiayue, Lou, Feng, Cao, Shanbo, Wang, Chengcheng, Yu, Wenjuan, Tong, Hongyan, Meng, Haitao, Huang, Jian, Zhu, Honghu, Jin, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796117/
https://www.ncbi.nlm.nih.gov/pubmed/35096581
http://dx.doi.org/10.3389/fonc.2021.783114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796117/
https://www.ncbi.nlm.nih.gov/pubmed/35096581
http://dx.doi.org/10.3389/fonc.2021.783114

Ejemplares similares